Kerstin Kühn-Wache

Title: Kerstin Kühn-Wache: Innovator in Dipeptidyl Peptidase IV Research

Introduction

Kerstin Kühn-Wache is a notable inventor based in Halle/Saale, Germany. She has made significant contributions to the field of biochemistry, particularly in the study of dipeptidyl peptidase IV (DP IV). With a total of 2 patents, her work has implications for treating various disorders related to this enzyme.

Latest Patents

Kerstin's latest patents include innovative methods related to the secondary binding site of dipeptidyl peptidase IV. The first patent discusses the relationship of this secondary binding site among substrates and its role in modulating substrate specificity. It also covers compounds that bind to this site and their potential use in treating DP IV mediated disorders. The second patent describes a method for raising blood sugar levels in hypoglycemic mammals by administering inhibitors of dipeptidyl peptidase IV, thereby reducing the degradation of glucagon.

Career Highlights

Throughout her career, Kerstin has worked with prominent companies such as Probiodrug and Osi Pharmaceuticals, Inc. Her research has been pivotal in advancing the understanding of DP IV and its applications in medical treatments.

Collaborations

Kerstin has collaborated with esteemed colleagues, including Hans-Ulrich Demuth and Torsten Hoffmann. Their joint efforts have contributed to the advancement of research in the field of biochemistry.

Conclusion

Kerstin Kühn-Wache's innovative work in the realm of dipeptidyl peptidase IV research showcases her dedication to advancing medical science. Her patents and collaborations highlight her significant impact in this important area of study.